﻿<?xml version="1.0" encoding="utf-8"?><affair xmlns:i="http://www.w3.org/2001/XMLSchema-instance"><id>20105597</id><updated>2023-07-28T12:19:53Z</updated><additionalIndexing>2841;Versicherungsleistung;Kanton;Krankenversicherung;Evaluation;Impfstoff;Krebs;Impfung;Frau</additionalIndexing><affairType><abbreviation>Fra.</abbreviation><id>14</id><name>Fragestunde. Frage</name></affairType><author><councillor><code>2683</code><gender>f</gender><id>3880</id><name>Geissbühler Andrea Martina</name><officialDenomination>Geissbühler</officialDenomination></councillor><faction><abbreviation>Fraktion V</abbreviation><code>V</code><id>4</id><name>Fraktion der Schweizerischen Volkspartei</name></faction><type>author</type></author><deposit><council><abbreviation>NR</abbreviation><id>1</id><name>Nationalrat</name><type>N</type></council><date>2010-12-13T00:00:00Z</date><legislativePeriod>48</legislativePeriod><session>4816</session></deposit><descriptors><descriptor><key>L06K010505070101</key><name>Impfung</name><type>1</type></descriptor><descriptor><key>L04K01050110</key><name>Krebs</name><type>1</type></descriptor><descriptor><key>L05K0107010301</key><name>Frau</name><type>1</type></descriptor><descriptor><key>L05K0105030104</key><name>Impfstoff</name><type>1</type></descriptor><descriptor><key>L06K080701020108</key><name>Kanton</name><type>1</type></descriptor><descriptor><key>L04K01040109</key><name>Krankenversicherung</name><type>2</type></descriptor><descriptor><key>L05K1110011304</key><name>Versicherungsleistung</name><type>2</type></descriptor><descriptor><key>L04K08020302</key><name>Evaluation</name><type>2</type></descriptor></descriptors><drafts><draft><consultation><resolutions /></consultation><federalCouncilProposal><date>2010-12-13T00:00:00Z</date></federalCouncilProposal><index>0</index><links /><preConsultations /><references /><relatedDepartments><relatedDepartment><abbreviation>EDI</abbreviation><id>4</id><name>Departement des Innern</name><leading>true</leading></relatedDepartment></relatedDepartments><states><state><date>2010-12-13T00:00:00</date><id>229</id><name>Erledigt</name></state></states><texts /></draft></drafts><language>de</language><relatedAffairs /><roles><role><councillor><code>2683</code><gender>f</gender><id>3880</id><name>Geissbühler Andrea Martina</name><officialDenomination>Geissbühler</officialDenomination></councillor><faction><abbreviation>Fraktion V</abbreviation><code>V</code><id>4</id><name>Fraktion der Schweizerischen Volkspartei</name></faction><type>author</type></role></roles><shortId>10.5597</shortId><state><id>229</id><name>Erledigt</name><doneKey>0</doneKey><newKey>0</newKey></state><texts><text><type><id>14</id><name>Antwort BR / Büro</name></type><value>&lt;p&gt;Die Antwort des Bundesrates existiert nur in französischer Sprache.&lt;/p&gt;</value></text><text><type><id>5</id><name>Eingereichter Text</name></type><value>&lt;p&gt;1. Wie viele lmpfstoffdosen wurden vom Bund angekauft?&lt;/p&gt;&lt;p&gt;2. Wie viele lmpfstoffdosen wurden von den Kantonen gebraucht?&lt;/p&gt;&lt;p&gt;3. Warum will der Bundesrat den Impfstoff in die Grundversicherung aufnehmen, ohne dass Langzeitstudien vorliegen?&lt;/p&gt;</value></text><text><type><id>1</id><name>Titel des Geschäftes</name></type><value>Umstrittene HPV-Impfung gegen Gebärmutterhalskrebs</value></text></texts><title>Umstrittene HPV-Impfung gegen Gebärmutterhalskrebs</title></affair>